{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-082739","form_type":"8-K","ticker":"ELDN","cik":"0001404281","company_name":"Eledon Pharmaceuticals, Inc.","filed_at":"2024-07-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.930429+00:00","generated_at":"2026-05-31T21:59:59.129737+00:00","sec_items":["3.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Eledon Pharmaceuticals completes $2.1M unregistered stock sale of 909,088 shares","bullets":["Sold 909,088 shares of common stock in second closing under Securities Purchase Agreement dated April 28, 2023.","Gross proceeds of approximately $2.1 million from institutional and accredited investors.","Exempt from registration under Section 4(a)(2) and Rule 506(b)."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-082739","json":"https://secwatch.observer/filing/0000950170-24-082739.json","markdown":"https://secwatch.observer/filing/0000950170-24-082739.md","text":"https://secwatch.observer/filing/0000950170-24-082739.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1404281/000095017024082739/0000950170-24-082739-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1404281/000095017024082739/eldn-20240708.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T21:59:59.129737+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}